Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Exosomes Diagnostic and Therapeutic Market Growth Outlook 2024 to 2034

Increasing demand for non-invasive biomarkers to catapult growth in the exosome diagnostic and therapeutic market. The market size is expected to increase from US$ 88.56 million in 2024 to US$ 211.6 million by 2034, at a 9.10% CAGR.

Attributes Key Insights
Estimated Exosomes Diagnostic and Therapeutic Market Size (2024E) US$ 88.56 million
Projected Exosomes Diagnostic and Therapeutic Market Valuation (2034F) US$ 211.6 million
Value-based CAGR (2024 to 2034) 9.10%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Emerging Trends and Opportunities in the Exosomes Diagnostic and Therapeutic Market

The healthcare sector is facing pressure to reduce the prices of healthcare services to increase their accessibility among the rising patient population. In this regard, laboratories are adopting solutions that are integrated with informatics. This helps boost productivity with the help of available resources.

Manufacturers are taking an opportunistic approach by offering such healthcare facilities with additional services and support in terms of diagnostic test products. Consequently, contributes to market growth.

Key players are also capitalizing on the growing demand for non-invasive tests to diagnose cancer. For this, they continue to maintain partnerships with academic institutes to develop novel non-invasive diagnostics.

Overview of Markets Adjacent to the Global Exosomes Diagnostic and Therapeutic Industry

Exosomes diagnostic and therapeutic market players can explore their potential in the liquid biopsy market and cancer diagnostic market. These markets offer a significant scope for expansion. Liquid biopsy, especially, is expected to present massive potential, as the market is estimated to record a 21.7% CAGR. A key driver for this market is increasing progress in personalized healthcare treatment.

Exosomes Diagnostic and Therapeutic Market:

Attributes Exosomes Diagnostic and Therapeutic Market
CAGR (2024 to 2034) 9.10%
Growth Factor Rising demand for non-invasive tests
Opportunity Increasing opportunities in exosome-based therapy
Key Trends Increasing clinical applications of exosome biomarkers

Liquid Biopsy Market:

Attributes Liquid Biopsy Market
CAGR (2024 to 2034) 21.7%
Growth Factor Surging cancer population
Opportunity Growth in government-led initiatives
Key Trends Rising research and development to develop a better version of liquid biopsy

Cancer Diagnostic Market:

Attributes Cancer Diagnostic Market
CAGR (2024 to 2034) 8.5%
Growth Factor
  • Growing concentration of healthcare experts to develop efficient diagnosis and treatment solutions to decrease the incidence rate
  • Key companies and healthcare institutions are increasing routine exams via various awareness efforts
Opportunity Government activities and other private groups are increasingly spreading awareness prevention and early detection of cancer
Key Trends Enhancing infrastructure of diagnostic laboratory
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Exosomes Diagnostic and Therapeutic Market Analysis

Exosomes are Excessively Used for Diagnostic Purposes

Leading Application Diagnostics
Value Share (2024) 68.0%

Based on application, the exosome-based diagnostics segment acquired a massive value share of 68% in 2023. Significant use of exosomes for diagnostic purposes can be attributed to their effective delivery of specific disease cells like nucleic acids and proteins. Exosome diagnostic tests are presently being developed for several diseases like infectious diseases, cancer, and neurological disorders.

Instruments Segment to Capture a Sizeable Market Share

Leading Product Type Instruments
Value Share (2024) 25.0%

By product type, the instruments segment accounts for a prominent share of 25% in the exosomes diagnostic and therapeutic market. The segment is driven by rapid advancements in research and development activities in the healthcare sector. Growth in the count of manufacturers providing instruments for diagnostic and therapeutic is also propelling the segment expansion.

Global Exosomes Diagnostic and Therapeutic Sales Analysis by Country

Countries Forecast CAGR (2024 to 2034)
The United States 4.50%
Canada 5.0%
Germany 3.80%
China 10.0%
India 9.50%

Research Groups in the United States Make Breakthroughs in Cancer Diagnosis with Exosomes

Market players are exploiting the potential for the exosome diagnostic and therapeutic industry in the United States, which is estimated to grow at 4.5% CAGR over the forecast period. Exosomes have been receiving significant traction over the past few years due to their remarkable therapeutic possibilities.

They can be harnessed for focused delivery of therapeutic agents, like nucleic acids, proteins, and pharmaceuticals, nucleic acids, throughout biological barriers. This attribute holds a lot of potential in precision medicine applications, especially in cancer therapy.

Numerous cutting-edge technologies and the latest strategies have been developed to harness the capability of exosomes to enhance the efficiency and precision of cancer detection. These approaches can revolutionize cancer diagnostics, offering non-invasive, more precise, and early detection methods.

Liquid biopsies are one such disruptive strategy in cancer treatment, which uses non-invasive collection and investigation of exosomes from body fluids like urine, blood, and saliva.

The rapid increase in cancer patients and surging funding for cancer-related research are expected to continue supporting the exosome diagnostic and therapeutic industry in the United States.

Researchers in Canada Explore Urinary Exosomes for Disease Diagnosis

Adoption of exosomes diagnostic and therapeutic in Canada is projected to surge at a CAGR of 5% through 2034. Growth of this industry is increasing as researchers are trying to understand the connection between kidney function and disorders and urinary exosomes since exosomes carry cargo across kidney cells.

The availability, non-invasive nature, and ease of sample collection of urinary exosomes make them remarkable. Non-invasive exosomes offer a cost-effective way to uncover disease causes and therapeutic targets owing to their prognostic and diagnostic sensitivity. Additionally, non-invasive biomarkers have more patient and clinical adoption than their invasive counterparts.

Conveniently distributable and cost-effective distributable urinary indicators are clinically accessible. These factors contribute to the growth of the exosomes diagnostic and therapeutic market.

Advanced Diagnostic Assays in Germany Encourage the Exosomes Diagnostic and Therapeutic Industry

The scope of exosomes diagnostic and therapeutic in Germany is estimated to expand at a CAGR of 3.80% over the next 10 years. The industry is expected to be propelled by the increasing count of research activities with a focus on applications of exosomes to access the therapeutic effects of stem cells within the country.

Growing demand for advanced diagnostic assays as well as the increasing incidence of cancer in Germany are contributing to exosomes diagnostic and therapeutic market growth. Certain common factors that are compelling growth in the industry include advancements in healthcare systems and surging funding for research and development in Germany.

Increasing Cases of Diseases in India Draws Investors’ Interest

Investments in the Indian market are projected to rise at a CAGR of 9.5% in the following decade. Increasing cases of diseases like infectious disorders, cancer, and neurological diseases in India are raising the demand for more effective treatment and diagnostic tools offered by exosomes.

Ongoing technological advancements like proteomic analysis and high-throughput techniques are facilitating the characterization and identification of exosomes. Along with this, technological progress is helping in the development of diagnostic therapies and tools based on exosomes.

Surging investments from government agencies, private investors, and pharmaceutical firms are promoting research and growth in exosome diagnostics and therapeutics. With improving regulatory acceptance for exosome-based products, the market is set for significant expansion.

China to Observe Robust Growth Over the Next Decade as Non-invasive Testing Rises in Acceptability

Demand for exosome diagnostic and therapeutic in China is expected to rise at a CAGR of 10% over the forecast period. The market is driven by an increase in clinically researched and perceived applications of exosomes as smart nano-platforms for therapy and diagnosis in the country. Additionally, market players in China are increasing their efforts to exhibit the utility of exosomes in non-invasive testing to accelerate its adoption.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The exosome diagnostic and therapeutic industry is experiencing a high level of competition, thanks to the growing count of companies manufacturing exosome-based products. All known companies in the market are covered below. Along with the companies, the technology that they are working on is also described. The following companies may or may not be working with any regulatory agencies, however, many of them do.

AcouSort AB

It is a Swedish firm that is introducing a revolutionary acoustofluidic technology and working on exosome-based diagnostics. The European Innovation Council (EIC) rewarded AcouSort and its project partners with a total of US$ 2.5 million to create acoustofluidic thin-film actuated chip to separate exosomes from blood.

Aethlon Medical, Inc.

It is a United States-based company that focuses on addressing the unmet requirements in the global health and biodefense industry. The firm began its tumor-derived exosome research when the medical community held a view that exosomes are cellular debris.

Fast-forward to the present, a therapeutic to attend to tumor-derived exosomes presents a significant gap in cancer care. Aethlon has shown that Hemopurifier®’s affinity mechanism can detect tumor-derived exosomes behind various forms of cancer, like ovarian, breast, and metastatic melanoma.

AGC Biologics

AGC Biologics came into a service agreement with Japan’s Jikei University in April 2023. This agreement states that AGC Biologics is going to assume a feasibility study and technology transfer for a drug to cure idiopathic pulmonary fibrosis (IPF). Specifically, the ACG scientists are going to focus on recognizing the viability of developing a sample for an exosome-based treatment.

Aruna Bio

The company is leveraging the natural abilities of neural exosomes to pass the blood-brain barrier and elevate the body’s anti-inflammatory, protective, and self-repair mechanisms for neurodegenerative disorders treatment.

Latest Developments in the Exosomes Diagnostic and Therapeutic Market

  • Thermo Fisher Scientific introduced the Thermo Scientific KingFisher Apex Purification System in April 2021. This system is a high-throughput sample purification tool that is developed for scientists who want to automate the extraction of RNA, DNA, cells, and protein from an array of sample types. The system helps enhance research productivity and propel discoveries by automating and simplifying the sample preparation workflow.
  • In February 2022, Bio-Techne Corporation made public its agreement with Thermo Fisher Scientific. Under this agreement, the latter company will be helping a Bio-Techne brand called Exosome Diagnostics to develop and commercialize the ExoTRU kidney transplant rejection test.

Key Coverage in the Global Exosomes Diagnostic and Therapeutic Market Research Report

  • Adjacent Study of Exosome Technologies Market, Exosome Biomarkers Market, Exosome Isolation Kits Market, Exosome Analysis Market, and Exosome Therapeutics Market
  • Market Dynamics of Exosome Isolation Kits are Mentioned

Key Players in the Exosomes Diagnostic and Therapeutic Market

  • Thermo Fisher Scientific
  • NanoSomix
  • NX Pharmagen
  • Malvern Instruments
  • Capricor Therapeutic
  • Exosome Diagnostics
  • Exiqon A/S
  • System Biosciences
  • Exosome Sciences
  • Aegle Therapeutic
  • AMS Biotechnology
  • Miltenyi Biotec
  • Codiak BioSciences Inc.
  • Lonza Group (HansaBioMed Life Sciences Ltd.)
  • AcouSort AB
  • Aethlon Medical, Inc.
  • AGC Biologics
  • Anjarium Biosciences AG
  • Aruna Bio
  • Brexogen
  • Capricor Therapeutics
  • Cells for Cells
  • Ciloa
  • ConvEyXO
  • Others

Exosomes Diagnostic and Therapeutic Market Research by Categories

By Products for Exosomes Diagnostic and Therapeutic are as follows:

  • Instruments
  • Software
  • Reagents and Kits

The Market is Bifurcated Based on Applications as:

  • Diagnostics
  • Therapeutic

Key End Users of Exosomes Diagnostic and Therapeutic are:

  • Hospitals
  • Cancer Institutes
  • Diagnostic Centers
  • Others

Different Markets for Exosomes Diagnostic and Therapeutic are:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

What is the Market Valuation of Exosomes Diagnostic and Therapeutic Market as of 2024?

For the year 2024, the exosomes diagnostic and therapeutic industry is estimated to be valued at US$ 88.56 million.

What is the Projected Adoption Rate of Exosomes Diagnostic and Therapeutic for the Years Between 2024 to 2034?

The adoption rate of exosomes diagnostic and therapeutic is calculated to be around 9.10% for the forecast period.

How Much Revenue this Industry is Expected to Generate by 2034?

The market revenue is expected to shoot up to US$ 211.6 million by 2034.

Which Application Segment Grabs a Hefty Share in Exosomes Diagnostic and Therapeutic?

The diagnostics segment grabs a hefty share within the exosomes diagnostic and therapeutic industry.

Which Country is Expected to Expand at a Greater Pace?

China is expected to register a significant growth rate in the exosomes diagnostic and therapeutic industry.

Which Players in the Exosomes Diagnostic and Therapeutic Industry are Influential?

Anjarium Biosciences AG, Aruna Bio, and Brexogen are influential players in the exosome diagnostic and therapeutic industry.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034

        5.3.1. Instruments

        5.3.2. Software

        5.3.3. Reagents & Kits

    5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        6.3.1. Diagnostics

        6.3.2. Therapeutic

    6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034

        7.3.1. Hospitals

        7.3.2. Cancer Institutes

        7.3.3. Diagnostic Centres

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Component

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Component

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Component

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Component

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Component

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Component

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Component

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Component

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Component

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Component

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Component

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Component

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Component

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Component

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Market Share Analysis, 2023

            16.1.1.1. By Component

            16.1.1.2. By Application

            16.1.1.3. By End User

    16.2. Canada

        16.2.1. Market Share Analysis, 2023

            16.2.1.1. By Component

            16.2.1.2. By Application

            16.2.1.3. By End User

    16.3. Brazil

        16.3.1. Market Share Analysis, 2023

            16.3.1.1. By Component

            16.3.1.2. By Application

            16.3.1.3. By End User

    16.4. Mexico

        16.4.1. Market Share Analysis, 2023

            16.4.1.1. By Component

            16.4.1.2. By Application

            16.4.1.3. By End User

    16.5. Germany

        16.5.1. Market Share Analysis, 2023

            16.5.1.1. By Component

            16.5.1.2. By Application

            16.5.1.3. By End User

    16.6. UK

        16.6.1. Market Share Analysis, 2023

            16.6.1.1. By Component

            16.6.1.2. By Application

            16.6.1.3. By End User

    16.7. France

        16.7.1. Market Share Analysis, 2023

            16.7.1.1. By Component

            16.7.1.2. By Application

            16.7.1.3. By End User

    16.8. Spain

        16.8.1. Market Share Analysis, 2023

            16.8.1.1. By Component

            16.8.1.2. By Application

            16.8.1.3. By End User

    16.9. Italy

        16.9.1. Market Share Analysis, 2023

            16.9.1.1. By Component

            16.9.1.2. By Application

            16.9.1.3. By End User

    16.10. Poland

        16.10.1. Market Share Analysis, 2023

            16.10.1.1. By Component

            16.10.1.2. By Application

            16.10.1.3. By End User

    16.11. Russia

        16.11.1. Market Share Analysis, 2023

            16.11.1.1. By Component

            16.11.1.2. By Application

            16.11.1.3. By End User

    16.12. Czech Republic

        16.12.1. Market Share Analysis, 2023

            16.12.1.1. By Component

            16.12.1.2. By Application

            16.12.1.3. By End User

    16.13. Romania

        16.13.1. Market Share Analysis, 2023

            16.13.1.1. By Component

            16.13.1.2. By Application

            16.13.1.3. By End User

    16.14. India

        16.14.1. Market Share Analysis, 2023

            16.14.1.1. By Component

            16.14.1.2. By Application

            16.14.1.3. By End User

    16.15. Bangladesh

        16.15.1. Market Share Analysis, 2023

            16.15.1.1. By Component

            16.15.1.2. By Application

            16.15.1.3. By End User

    16.16. Australia

        16.16.1. Market Share Analysis, 2023

            16.16.1.1. By Component

            16.16.1.2. By Application

            16.16.1.3. By End User

    16.17. New Zealand

        16.17.1. Market Share Analysis, 2023

            16.17.1.1. By Component

            16.17.1.2. By Application

            16.17.1.3. By End User

    16.18. China

        16.18.1. Market Share Analysis, 2023

            16.18.1.1. By Component

            16.18.1.2. By Application

            16.18.1.3. By End User

    16.19. Japan

        16.19.1. Market Share Analysis, 2023

            16.19.1.1. By Component

            16.19.1.2. By Application

            16.19.1.3. By End User

    16.20. South Korea

        16.20.1. Market Share Analysis, 2023

            16.20.1.1. By Component

            16.20.1.2. By Application

            16.20.1.3. By End User

    16.21. GCC Countries

        16.21.1. Market Share Analysis, 2023

            16.21.1.1. By Component

            16.21.1.2. By Application

            16.21.1.3. By End User

    16.22. South Africa

        16.22.1. Market Share Analysis, 2023

            16.22.1.1. By Component

            16.22.1.2. By Application

            16.22.1.3. By End User

    16.23. Israel

        16.23.1. Market Share Analysis, 2023

            16.23.1.1. By Component

            16.23.1.2. By Application

            16.23.1.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Component

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Thermo Fisher Scientific

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. NanoSomix

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. NX Pharmagen

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Malvern Instruments

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Capricor Therapeutic

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Exosome Diagnostics

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Exiqon A/S

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. System Biosciences

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Exosome Sciences

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Aegle Therapeutic

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. AMS Biotechnology

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Miltenyi Biotec

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Codiak BioSciences Inc.

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 4: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 6: North America Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 7: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 8: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 10: Latin America Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Western Europe Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 15: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: East Asia Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 27: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Component, 2019 to 2034

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Component, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 8: Global Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 9: Global Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 10: Global Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 11: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 14: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 17: Global Market Attractiveness by Component, 2024 to 2034

Figure 18: Global Market Attractiveness by Application, 2024 to 2034

Figure 19: Global Market Attractiveness by End User, 2024 to 2034

Figure 20: Global Market Attractiveness by Region, 2024 to 2034

Figure 21: North America Market Value (US$ Million) by Component, 2024 to 2034

Figure 22: North America Market Value (US$ Million) by Application, 2024 to 2034

Figure 23: North America Market Value (US$ Million) by End User, 2024 to 2034

Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 28: North America Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 29: North America Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 30: North America Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 31: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 34: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 37: North America Market Attractiveness by Component, 2024 to 2034

Figure 38: North America Market Attractiveness by Application, 2024 to 2034

Figure 39: North America Market Attractiveness by End User, 2024 to 2034

Figure 40: North America Market Attractiveness by Country, 2024 to 2034

Figure 41: Latin America Market Value (US$ Million) by Component, 2024 to 2034

Figure 42: Latin America Market Value (US$ Million) by Application, 2024 to 2034

Figure 43: Latin America Market Value (US$ Million) by End User, 2024 to 2034

Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 48: Latin America Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 57: Latin America Market Attractiveness by Component, 2024 to 2034

Figure 58: Latin America Market Attractiveness by Application, 2024 to 2034

Figure 59: Latin America Market Attractiveness by End User, 2024 to 2034

Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 61: Western Europe Market Value (US$ Million) by Component, 2024 to 2034

Figure 62: Western Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 63: Western Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 68: Western Europe Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 71: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 77: Western Europe Market Attractiveness by Component, 2024 to 2034

Figure 78: Western Europe Market Attractiveness by Application, 2024 to 2034

Figure 79: Western Europe Market Attractiveness by End User, 2024 to 2034

Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 81: Eastern Europe Market Value (US$ Million) by Component, 2024 to 2034

Figure 82: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 97: Eastern Europe Market Attractiveness by Component, 2024 to 2034

Figure 98: Eastern Europe Market Attractiveness by Application, 2024 to 2034

Figure 99: Eastern Europe Market Attractiveness by End User, 2024 to 2034

Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 101: South Asia and Pacific Market Value (US$ Million) by Component, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034

Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034

Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 117: South Asia and Pacific Market Attractiveness by Component, 2024 to 2034

Figure 118: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034

Figure 119: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034

Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 121: East Asia Market Value (US$ Million) by Component, 2024 to 2034

Figure 122: East Asia Market Value (US$ Million) by Application, 2024 to 2034

Figure 123: East Asia Market Value (US$ Million) by End User, 2024 to 2034

Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 128: East Asia Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 129: East Asia Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 131: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 137: East Asia Market Attractiveness by Component, 2024 to 2034

Figure 138: East Asia Market Attractiveness by Application, 2024 to 2034

Figure 139: East Asia Market Attractiveness by End User, 2024 to 2034

Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 141: Middle East and Africa Market Value (US$ Million) by Component, 2024 to 2034

Figure 142: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034

Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Component, 2019 to 2034

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Component, 2024 to 2034

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 157: Middle East and Africa Market Attractiveness by Component, 2024 to 2034

Figure 158: Middle East and Africa Market Attractiveness by Application, 2024 to 2034

Figure 159: Middle East and Africa Market Attractiveness by End User, 2024 to 2034

Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Recommendations

Healthcare

Medical Exoskeleton Market

Published : February 2024

Healthcare

Diagnostic Exosome Biomarkers Market

Published : August 2023

Explore Healthcare Insights

View Reports

Exosomes Diagnostic and Therapeutic Market